Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection

Journal of Medical Virology

Volumn 78, Issue 6, 2006, Pages 770-779

  Shibata, Yukiko ^a   Hoshino, Yo ^a   Hara, Shinya ^a   Yagasaki, Hiroshi ^a   Kojima, Seiji ^a   Nishiyama, Yukihiro ^a   Morishima, Tsuneo ^b   Kimura, Hiroshi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Chronic active EBV infection; Infectious mononucleosis; LMP1

Indexed keywords

GENE PRODUCT; LATENT MEMBRANE PROTEIN 1;

ADOLESCENT; ADULT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INFECTIOUS MONONUCLEOSIS; JAPAN; LMP1 GENE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; SYSTEMIC DISEASE; VIRUS GENE; VIRUS INFECTION; VIRUS STRAIN;

ADOLESCENT; ADULT; ANIMALS; BASE SEQUENCE; CALLITHRIX; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MOLECULAR SEQUENCE DATA; VARIATION (GENETICS); VIRAL LOAD; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 33646494522     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20622     Document Type: Article

References (50)

1. Anagnostopoulos A, Giralt S. 2002. Critical review on non-myeloablative stem cell transplantation (NST). Crit Rev Oncol Hematol 44:175-190.
2. Brooks L, Yao QY, Rickinson AB, Young LS. 1992. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66:2689-2697.
3. Chen CL, Sadler RH, Walling DM, Su IJ, Hsieh HC, Raab-Traub N. 1993. Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol 67:6303-6308.
4. Cohen JI. 2000. Epstein-Barr virus infection. N Engl J Med 343:481-492.
5. DeFilipis VR, Villarreal LP. 2001. Virus evolution. In: Knipe DM, Howley PM, editors. Virology. Philadelphia: Lippincott Williams and Wilkins. pp 353-370.
6. Eckert KA, Kunkel TA. 1990. High fidelity DNA synthesis by the Thermus aquaticus DNA polymerase. Nucleic Acids Res 18:3739-3744.
7. Edwards RH, Seillier-Moiseiwitsch F, Raab-Traub N. 1999. Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. Virology 261:79-95.
8. Endo R, Yoshioka M, Ebihara T, Ishiguro N, Kikuta H, Kobayashi K. 2004. Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection. Med Hypotheses 63:582-587.
9. Fujieda M, Wakiguchi H, Hisakawa H, Kubota H, Kurashige T. 1993. Defective activity of Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes in children with chronic active EBV infection and in their parents. Acta Paediatr Jpn 35:394-399.
10. Gaudy C, Lambele M, Moreau A, Veillon P, Lunel F, Goudeau A. 2005. Mutations within the hepatitis C virus genotype 1b E2-PePHD domain do not correlate with treatment outcome. J Clin Microbiol 43:750-754.
11. Hoshino Y, Morishima T, Kimura H, Nishikawa K, Tsurumi T, Kuzushima K. 1999. Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection. J Immunol 163:5735-5740.
12. Imai S, Sugiura M, Oikawa O, Koizumi S, Hirao M, Kimura H, Hayashibara H, Terai N, Tsutsumi H, Oda T, Chiba S, Osato T. 1996. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 87:1446-1457.
13. Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, Sands J, Gottman D, Katz BZ, Sklar J. 1988. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318:733-741.
14. Kanegane H, Bhatia K, Gutierrez M, Kaneda H, Wada T, Yachie A, Seki H, Arai T, Kagimoto S, Okazaki M, Oh-ishi T, Moghaddam A, Wang F, Tosato G. 1998. A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma. Blood 91:2085-2091.
15. Kasahara Y, Yachie A. 2002. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol 44:283-294.
16. Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, Hara J, Murayama F, Tawa A, Hirai K. 1989. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 84:51-55.
17. Khanim F, Yao QY, Niedobitek G, Sihota S, Rickinson AB, Young LS. 1996. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 88:3491-3501.
18. Kieff E, Rickinson AB. 2001. Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, editors. Virology. 4th edition. Philadelphia: Lippincott Williams and Wilkins. pp 2511-2573.
19. Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishizaka A, Sakiyama Y, Matsumoto S, Imai S, Kinoshita T, et al. 1988. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333:455-457.
20. Kimura H, Tsuge I, Imai S, Yamamoto M, Kuzushima K, Osato T, Morishima T. 1995. Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infection. Med Microbiol Immunol (Berl) 184:63-68.
21. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T, Morishima T. 1999. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 37:132-136.
22. Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T. 2001. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 98:280-286.
23. Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, Imai S, Okano M, Morio T, Yokota S, Tsuchiya S, Yachie A, Imashuku S, Kawa K, Wakiguchi H. 2003. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 187:527-533.
24. Kimura H, Hoshino Y, Hara S, Sugaya N, Kawada J, Shibata Y, Kojima S, Nagasaka T, Kuzushima K, Morishima T. 2005. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis 191:531-539.
25. Kuzushima K, Yamamoto M, Kimura H, Ando Y, Kudo T, Tsuge I, Morishima T. 1996. Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection. Clin Exp Immunol 103:192-198.
26. Maloney DG, Sandmaier BM, Mackinnon S, Shizuru JA. 2002. Nonmyeloablative transplantation. Hematology (Am Soc Hematol Educ Program) 1:392-421.
27. Miller WE, Edwards RH, Walling DM, Raab-Traub N. 1994. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol 75:2729-2740.
28. Mitarnun W, Suwiwat S, Pradutkanchana J, Saechan V, Ishida T, Takao S, Mori A. 2002. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: Clinicopathologic, serologic, and molecular analysis. Am J Hematol 70:31-38.
29. Ohga S, Kimura N, Takada H, Nagano M, Ohshima K, Nomura A, Muraoka K, Take H, Yamamori S, Hara T. 1999. Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: Potential inclination to T-lymphoproliferative disease. Am J Hematol 61:26-33.
30. Okamura T, Hatsukawa Y, Arai H, Inoue M, Kawa K. 2000. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation. Lancet 356:223-224.
31. Okano M, Matsumoto S, Osato T, Sakiyama Y, Thiele GM, Purtilo DT. 1991. Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev 4:129-135.
32. Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES. 2000. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: A distinct clinicopathologic syndrome. Blood 96:443-451.
33. Raab-Traub N, Flynn K. 1986. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889.
34. Rickinson AB. 1986. Chronic, symptomatic Epstein-Barr virus infection. Immunol Today 7:13-14.
35. Rickinson AB, Kieff E. 2001. Epstein-Barr virus. In: Knipe DM, Howley PM, editors. Virology. 4th edition. Philadelphia: Lippincott Williams and Wilkins. pp 2575-2627.
36. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB. 1987. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6:2743-2751.
37. Savoldo B, Huls MH, Liu Z, Okamura T, Volk HD, Reinke P, Sabat R, Babel N, Jones JF, Webster-Cyriaque J, Gee AP, Brenner MK, Heslop HE, Rooney CM. 2002. Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection. Blood 100:4059-4066.
38. Schooley RT, Carey RW, Miller G, Henle W, Eastman R, Mark EJ, Kenyon K, Wheeler EO, Rubin RH. 1986. Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. Ann Intern Med 104:636-643.
39. Sculley TB, Apolloni A, Hurren L, Moss DJ, Cooper DA. 1990. Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis 162:643-648.
40. Srivastava G, Wong KY, Chiang AK, Lam KY, Tao Q. 2000. Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: Reassessment of the viral carrier state. Blood 95:2443-2445.
41. Straus SE. 1988. The chronic mononucleosis syndrome. J Infect Dis 157:405-412.
42. Sugaya N, Kimura H, Hara S, Hoshino Y, Kojima S, Morishima T, Tsurumi T, Kuzushima K. 2004. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection. J Infect Dis 190:985-988.
43. Tatusova TA, Madden TL. 1999. BLAST 2 sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol Lett 174:247-250.
44. Toyabe S, Harada W, Uchiyama M. 2003. Biclonal expansion of T cells infected with monoclonal Epstein-Barr virus (EBV) in a patient with chronic, active EBV infection. Clin Exp Immunol 134:92-97.
45. Tsuge I, Morishima T, Morita M, Kimura H, Kuzushima K, Matsuoka H. 1999. Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line. Clin Exp Immunol 115:385-392.
46. Tsuge I, Morishima T, Kimura H, Kuzushima K, Matsuoka H. 2001. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection. J Med Virol 64:141-148.
47. Uehara T, Nakaseko C, Hara S, Harima A, Ejiri M, Yokota A, Saito Y, Nishimura M. 2004. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection. Am J Hematol 76:368-372.
48. Walling DM, Brown AL, Etienne W, Keitel WA, Ling PD. 2003. Multiple Epstein-Barr virus infections in healthy individuals. J Virol 77:6546-6550.
49. Walling DM, Andritsos LA, Etienne W, Payne DA, Aronson JF, Flaitz CM, Nichols CM. 2004. Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease. J Med Virol 74:94-101.
50. Yao QY, Croom-Carter DS, Tierney RJ, Habeshaw G, Wilde JT, Hill FG, Conlon C, Rickinson AB. 1998. Epidemiology of infection with Epstein-Barr virus types 1 and 2: Lessons from the study of a T-cell-immunocompromised hemophilic cohort. J Virol 72:4352-4363.